Many obesity medications believed to lower blood sugar levels Because both conditions share inflammatory components, repurposing medications already approved for obesity may be a potential treatment option for MS, research has suggested
Based on the estimated 3.8 million Part D enrollees eligible for the Medicare GLP-1 Bridge as of 2023, if 10% to 25% participate in Bridge from when the program launches in July 2026 and fill a prescription each month for the 18-month duration of the program, the cost to Medicare would be $1.3 billion to $3.3 billion (at a net monthly cost of $245 minus the $50 beneficiary copay)
The list of comparative drugs included oral antidiabetics, injectable insulin, and other GLP-1 receptor agonists such as exenatide, dulaglutide, and liraglutide
Why the injection route matters Wegovy (semaglutide) is formulated specifically for subcutaneous delivery, meaning its designed to release slowly through fatty tissue under the skin
B vitamins thiamine (B1) and cobalamin (B12) round out the cocktail, driving metabolism, preventing fat accumulation, and promoting weight loss
This product is suitable for both vegetarians and vegans
